Evidence map›Paper›PMID 41842586›Full record

ArticleJournal of proteome research2026

Systematic Evaluation of Depletion and Enrichment Technologies for Platelet-Free Plasma Proteomics.

Salem Al Siblani, Jean Armengaud, Clément Lozano

Abstract readEvaluation Study
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Salem Al SiblaniInstitut Hospitalo-Universitaire Comprehensive SEPSIS Center, Paris-Saclay University, 91190 Saclay, France.
Jean ArmengaudInstitut Hospitalo-Universitaire Comprehensive SEPSIS Center, Paris-Saclay University, 91190 Saclay, France.ORCID 0000-0003-1589-445X
Clément LozanoInstitut Hospitalo-Universitaire Comprehensive SEPSIS Center, Paris-Saclay University, 91190 Saclay, France.ORCID 0000-0001-9707-1857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma proteomics is a rapid, noninvasive, and highly informative approach for identifying disease biomarkers. However, the wide dynamic range of protein concentration limits the depth of liquid chromatography-tandem mass spectrometry proteomics. To address this challenge, we evaluated, with an Orbitrap Astral instrument using DIA, the performance of several protein depleting and enriching technologies on platelet-free plasma. Specifically, we assessed: perchloric acid depletion, immunodepletion, ProteoMiner, MagNet-SAX, ENRICHplus, Proteonano and the combination of ProteoMiner and immunodepletion. All methods were assessed in terms of proteomic depths, protein quantification precision, and functional analysis. Proteonano exhibited the most effective enrichment for the lowest abundance proteins, confidently identifying 299 proteins with mapped blood concentrations below 10

Indexed as

Blood ProteinsProteomeProteomicsHumansLiquid Chromatography-Mass SpectrometryReproducibility of ResultsTandem Mass SpectrometryBlood ProteinsProteomeASTRALDIAENRICHplusimmunodepletionMagNet-SAXPCA-Nplasma proteomicsplatelet-free plasmaProteoMinerProteonano

Identifiers

PMID41842586
PMCPMC13248010

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.